Activated Immune Cells in Parkinson's Disease (Q37873407)

24 August 2017

1 reference

title

Activated immune cells in Parkinson's disease (English)

1 reference

24 August 2017

Activated Immune Cells in Parkinson's Disease (English)

1 reference

https://api.crossref.org/works/10.1007/S11481-011-9280-9

1 December 2024

1 reference

Jun-Jun Cao

1

1 reference

24 August 2017

Kang-Sheng Li

series ordinal

2

1 reference

24 August 2017

Yan-Qin Shen

series ordinal

3

1 reference

24 August 2017

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=21553347

1 December 2024

publication date

10 May 2011

1 reference

full work available at URL

24 August 2017

http://link.springer.com/content/pdf/10.1007/s11481-011-9280-9.pdf

file format

Portable Document Format

1 reference

https://api.crossref.org/works/10.1007/S11481-011-9280-9

http://link.springer.com/article/10.1007/s11481-011-9280-9/fulltext.html

1 December 2024

1 reference

https://api.crossref.org/works/10.1007/S11481-011-9280-9

http://link.springer.com/content/pdf/10.1007/s11481-011-9280-9

1 December 2024

1 reference

https://api.crossref.org/works/10.1007/S11481-011-9280-9

Journal of Neuroimmune Pharmacology

1 December 2024

published in

1 reference

24 August 2017

volume

6

1 reference

24 August 2017

issue

3

1 reference

24 August 2017

page(s)

323-329

1 reference

T cell-microglial dialogue in Parkinson's disease and amyotrophic lateral sclerosis: are we listening?

24 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007/S11481-011-9280-9

Mechanism of action of glatiramer acetate in multiple sclerosis and its potential for the development of new applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11481-011-9280-9

Alterations of T-lymphocyte populations in Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11481-011-9280-9

Lymphocyte populations in Parkinson's disease and in rat models of parkinsonism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11481-011-9280-9

Inhibition of brain-derived neurotrophic factor and glial cell line-derived neurotrophic factor expression reduces dopaminergic sprouting in the injured striatum.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11481-011-9280-9

Therapeutic immunization protects dopaminergic neurons in a mouse model of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11481-011-9280-9

Nitrated alpha-synuclein immunity accelerates degeneration of nigral dopaminergic neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11481-011-9280-9

Immunocytochemical analysis of tumor necrosis factor and its receptors in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11481-011-9280-9

Cytokine release from microglia: differential inhibition by pentoxifylline and dexamethasone

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11481-011-9280-9

Development of neonatal murine microglia in vitro: changes in response to lipopolysaccharide and ischemia-like injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11481-011-9280-9

Epidemiology of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11481-011-9280-9

Chronic expression of low levels of tumor necrosis factor-alpha in the substantia nigra elicits progressive neurodegeneration, delayed motor symptoms and microglia/macrophage activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11481-011-9280-9

Progressive neurodegeneration and motor disabilities induced by chronic expression of IL-1beta in the substantia nigra.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11481-011-9280-9

Functional recovery in parkinsonian monkeys treated with GDNF

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11481-011-9280-9

In vivo imaging of microglial activation with [11C](R)-PK11195 PET in idiopathic Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11481-011-9280-9

Selective inhibition of NF-kappaB activation prevents dopaminergic neuronal loss in a mouse model of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11481-011-9280-9

Vasoactive intestinal peptide generates human tolerogenic dendritic cells that induce CD4 and CD8 regulatory T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11481-011-9280-9

Exendin-4 protects dopaminergic neurons by inhibition of microglial activation and matrix metalloproteinase-3 expression in an animal model of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11481-011-9280-9

Microglial and astrocytic involvement in a murine model of Parkinson's disease induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11481-011-9280-9

Neurodegeneration prevented by lentiviral vector delivery of GDNF in primate models of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11481-011-9280-9

The inflammatory reaction following 1-methyl-4-phenyl-1,2,3, 6-tetrahydropyridine intoxication in mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11481-011-9280-9

Evidence of active nerve cell degeneration in the substantia nigra of humans years after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine exposure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11481-011-9280-9

CD4 T cells from Copolymer-1 immunized mice protect dopaminergic neurons in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11481-011-9280-9

The function of microglia, either neuroprotection or neurotoxicity, is determined by the equilibrium among factors released from activated microglia in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11481-011-9280-9

GDNF: a glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11481-011-9280-9

Rate of cell death in parkinsonism indicates active neuropathological process

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11481-011-9280-9

Proteomic analysis of microglial contribution to mouse strain-dependent dopaminergic neurotoxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11481-011-9280-9

Activation of mixed glia by Abeta-specific Th1 and Th17 cells and its regulation by Th2 cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11481-011-9280-9

Characterization of the microglial phenotype under specific pro-inflammatory and anti-inflammatory conditions: Effects of oligomeric and fibrillar amyloid-beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11481-011-9280-9

Infiltration of Th1 and Th17 cells and activation of microglia in the CNS during the course of experimental autoimmune encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11481-011-9280-9

Microglial clearance function in health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11481-011-9280-9

Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11481-011-9280-9

Alzheimer's disease and Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11481-011-9280-9

An Essay on the Shaking Palsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11481-011-9280-9

Neuroprotective activities of CD4 CD25 regulatory T cells in an animal model of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11481-011-9280-9

Nitrated {alpha}-synuclein-induced alterations in microglial immunity are regulated by CD4 T cell subsets

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11481-011-9280-9

Proteomic studies of nitrated alpha-synuclein microglia regulation by CD4 CD25 T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11481-011-9280-9

Regulatory T cells attenuate Th17 cell-mediated nigrostriatal dopaminergic neurodegeneration in a model of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11481-011-9280-9

Microglia acquire distinct activation profiles depending on the degree of alpha-synuclein neuropathology in a rAAV based model of Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11481-011-9280-9

Innate and adaptive immunity for the pathobiology of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11481-011-9280-9

MHC class II positive microglia and lymphocytic infiltration are present in the substantia nigra and striatum in mouse model of Parkinson's disease

21 January 2018

1 reference

12 December 2020

Mice deficient in TNF receptors are protected against dopaminergic neurotoxicity: implications for Parkinson's disease

1 reference

12 December 2020

Regional difference in susceptibility to lipopolysaccharide-induced neurotoxicity in the rat brain: role of microglia

1 reference

12 December 2020

Microglial reaction in MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) induced Parkinson's disease mice model

1 reference

12 December 2020

Parkinson's disease and immunological abnormalities: increase of HLA-DR expression on monocytes in cerebrospinal fluid and of CD45RO T cells in peripheral blood.

1 reference

12 December 2020

An essay on the shaking palsy. 1817.

1 reference

12 December 2020

Infiltration of CD4 lymphocytes into the brain contributes to neurodegeneration in a mouse model of Parkinson disease.

1 reference

12 December 2020

Activated macrophages and microglia induce dopaminergic sprouting in the injured striatum and express brain-derived neurotrophic factor and glial cell line-derived neurotrophic factor

1 reference

12 December 2020

Adaptive immune regulation of glial homeostasis as an immunization strategy for neurodegenerative diseases

1 reference

12 December 2020

Vasoactive intestinal peptide generates CD4 CD25 regulatory T cells in vivo

1 reference

12 December 2020

Journal of Clinical Investigation

10

119

182

V Brochard

2009

1 reference

https://api.crossref.org/works/10.1007/S11481-011-9280-9

1 December 2024

Identifiers

1 reference

24 August 2017

1 reference